Specialties

Bio

Dr. Fluchel received his medical degree from Vanderbilt University School of Medicine, completed his Pediatric residency at Seattle Children´s Hospital, and his Pediatric Hematology and Oncology Fellowship at the Children’s Hospital of Philadelphia.

He joined the faculty of the University of Utah in 2007, where he is currently an Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology

Dr. Fluchel’s clinical interests include the treatment of all pediatric cancers and hematologic disorders, with an emphasis on neuroblastoma, hepatoblastoma, germ cell tumors, and the histiocytic disorders.

His primary research focuses on assessing the burden of care for families of pediatric oncology patients and developing methods to better serve patients from rural, immigrant and underserved communities. His research also includes studies designed to help physicians better understand the histiocytic disorders of Langerhans Cell Histiocytosis (LCH) and Hemophagocytic Lymphohistiocytosis (HLH).

Academic Office Locations

Academic Bio

Dr. Fluchel received his medical degree from Vanderbilt University School of Medicine, completed his Pediatric residency at Seattle Children´s Hospital, and his Pediatric Hematology and Oncology Fellowship at the Children’s Hospital of Philadelphia.

He joined the faculty of the University of Utah in 2007, where he is currently an Associate Professor of Pediatrics in the Division of Pediatric Hematology and Oncology. He is a Huntsman Cancer Institute investigator and a member of the Cancer Control and Population Sciences program.

Dr. Fluchel’s clinical interests include the treatment of all pediatric cancers and hematologic disorders, with an emphasis on neuroblastoma, hepatoblastoma, germ cell tumors, and the histiocytic disorders.

Dr. Fluchel’s research focuses on assessing the impact of geography on the morbidity, mortality and the burden of care in pediatric oncology patients with the goal of developing methods to better serve patients from rural, immigrant and underserved communities. He is currently a Pediatric Clinical Translational (PCAT) Scholar and was recently awarded a Translational Comparative Effiectivess Research (T-CER) NIH Institutional Career Enhancement Award for his research into cancer outcome disparities. His research is also supported by a Hyundai Hope on Wheels Childhood Cancer Research Grant.

Dr. Fluchel’s research also includes studies designed to help physicians better understand the histiocytic disorders of Langerhans Cell Histiocytosis (LCH) and Hemophagocytic Lymphohistiocytosis (HLH). His study utilizing the Utah Population Database to identify familial associations in LCH is funded by a grant from the Histiocytosis Association of America.